A detailed history of Savant Capital, LLC transactions in Inogen Inc stock. As of the latest transaction made, Savant Capital, LLC holds 17,223 shares of INGN stock, worth $192,725. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,223
Previous 17,723 2.82%
Holding current value
$192,725
Previous $144,000 15.97%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$7.67 - $12.98 $3,835 - $6,490
-500 Reduced 2.82%
17,223 $167,000
Q2 2024

Aug 05, 2024

BUY
$6.3 - $8.95 $111,654 - $158,620
17,723 New
17,723 $144,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $256M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.